Literature DB >> 2326778

Low doses of activated protein C delay arterial thrombosis in rats.

M D Smirnov1, M V Pyzh, D V Borovikov, A N Atorozhilova, A B Dobrovolsky, V L Golubych, N A Gratsiansky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2326778     DOI： 10.1016/0049-3848(90)90082-n

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

Review 1.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

2.  Species-specific anticoagulant and mitogenic activities of murine protein S.

Authors:  José A Fernández; Mary J Heeb; Xiao Xu; Itender Singh; Berislav V Zlokovic; John H Griffin
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

Review 3.  Genetic susceptibility to inflammatory injury and various adverse outcomes.

Authors:  John M Murkin; Keith R Walley
Journal:  J Extra Corpor Technol       Date:  2009-03

4.  Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.

Authors:  B Arnljots; B Dahlbäck
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 5.  New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).

Authors:  William L Macias; S Betty Yan; Mark D Williams; Suzane L Um; George E Sandusky; Darryl W Ballard; Jean-Michel S Planquois
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

6.  Human activated protein C variants in a rat model of arterial thrombosis.

Authors:  Karl Malm; Björn Arnljots; Björn Dahlbäck
Journal:  Thromb J       Date:  2008-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.